The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...
The current state of health services highlights crucial sectors facing disruptions and developments, from US foreign aid freezes affecting disease control supply chains, to the FDA's actions on new ...
The Centers for Medicare & Medicaid Services reported ... beating its benchmark by 150 percentage points (see more details here). Novo Nordisk A/S (NYSE:NVO) is a global healthcare company ...
Novo Nordisk's stock closed about 5% higher on ... weight loss drugs such as Wegovy are not currently covered by Medicare and other insurance. Don't expect a 20% S&P 500 three-peat this year ...
Novo Nordisk's stock rose about 5% on Friday ... weight loss drugs such as Wegovy are not currently covered by Medicare and other insurance.
While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...